Compounds > stallimycin

stallimycin and hoe 33342

stallimycin has been researched along with hoe 33342 in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (50.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burres, NS; Frigo, A; McAlpine, JB; Rasmussen, RR	1
Schneider, HJ	1
Bell, SM; Dee, A; Smith, PJ; Sykes, H	1
Chen, AY; Gatto, B; Liu, LF; Yu, C	1
Hartley, JA; Hochhauser, D; Tolner, B	1
Brodbelt, JS; Keller, KM; Oehlers, L; Zhang, J	1

Reviews

1 review(s) available for stallimycin and hoe 33342

Article	Year
Ligand binding to nucleic acids and proteins: Does selectivity increase with strength? European journal of medicinal chemistry, 2008, Volume: 43, Issue:11 Topics: Ligands; Nucleic Acids; Proteins; Receptors, Opioid; Substrate Specificity	2008

Other Studies

5 other study(ies) available for stallimycin and hoe 33342

Article	Year
A colorimetric microassay for the detection of agents that interact with DNA. Journal of natural products, 1992, Volume: 55, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Colorimetry; DNA; Ethidium; Fermentation; Methyl Green; Spectrometry, Fluorescence	1992
Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons. Carcinogenesis, 1990, Volume: 11, Issue:4 Topics: Amsacrine; Animals; Anthramycin; Benzimidazoles; Benzodiazepinones; Cell Line; Cell Survival; Distamycins; DNA; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Intercalating Agents; Ligands; Mice; Mitoxantrone; Mutation; Nuclear Proteins; Pyrroles	1990
DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 1993, Sep-01, Volume: 90, Issue:17 Topics: Animals; Base Sequence; Benzimidazoles; Bisbenzimidazole; Cattle; Diminazene; Distamycins; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Indoles; Intercalating Agents; Kinetics; Ligands; Molecular Sequence Data; Oligodeoxyribonucleotides; Structure-Activity Relationship; Thymus Gland; Topoisomerase I Inhibitors	1993
Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs. Molecular pharmacology, 2001, Volume: 59, Issue:4 Topics: 3T3 Cells; Animals; Antigens, Neoplasm; Benzimidazoles; Bisbenzimidazole; Cell Line; Distamycins; DNA Footprinting; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Gene Expression Regulation; Humans; Isoenzymes; Mice; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic	2001
Influence of initial charge state on fragmentation patterns for noncovalent drug/DNA duplex complexes. Journal of mass spectrometry : JMS, 2005, Volume: 40, Issue:10 Topics: Benzimidazoles; Daunorubicin; Distamycins; DNA; Indoles; Netropsin; Nogalamycin; Oligodeoxyribonucleotides; Pharmaceutical Preparations; Spectrometry, Mass, Electrospray Ionization	2005